Chemicals industry market cap reset

By Robert Henske, Alexander Baumgartner, Everett Johnson and Brad McMullin

The global chemicals industry is undergoing a profound capital markets transformation. Market caps are shrinking, eligibility thresholds for major indices continue to rise, and the valuation gap between large- and small-cap companies is widening. For many players, this is not a cyclical dip – it is a structural reset that directly challenges long‑held assumptions about scale, competitiveness, and the role of public markets.

A structural reset reinventing the chemical industry’s capital market outlook

Over the past decade, the requirements for index inclusion have climbed sharply, driven in large part by the outsized growth of the technology sector. At the same time, chemical company valuations have moved in the opposite direction, declining at a median CAGR of -4.8% since 2017. As a result large-cap representation has plummeted from roughly 50% in 2017 to less than 15% today. Additionally, 65% of publicly listed chemical companies now fall into small‑cap or sub‑small‑cap categories. Companies that are falling below index thresholds are triggering forced selling, increased investor turnover, and heightened volatility.

What emerges is a clear pattern: scale is being aggressively repriced, and smaller companies face disproportionately higher pressure on valuation, liquidity, and cost of capital.

Structural headwinds limit the prospect of near-term recovery

Beyond capital markets dynamics, chemical companies are contending with three powerful structural forces shaping global competitiveness:

1. Chinese overcapacity is shifting the country from net importer to net exporter across major value chains.

2. Europe’s high-cost environment – from energy prices to regulatory burdens – continues to erode margins.

3. US tariff exposure introduces volatility and disrupts planning cycles, dampening CapEx and weakening cost positions.

In this environment, the traditional cyclical playbook is no longer sufficient.

Essential insights for leaders navigating the industry reset

Our latest report examines the market shifts in detail and defines the strategic actions leaders need to take to remain competitive.

This report outlines a data-driven understanding of the chemicals industry’s capital market reset, including how market caps, index thresholds, and valuation multiples have evolved since 2017 and what these shifts mean for companies of different sizes. The report also explores how falling below index eligibility affects ownership structures, accelerates investor turnover, and increases both volatility and cost of capital. Readers will gain a clear view of the structural forces reshaping global competitiveness – specifically Chinese overcapacity, Europe’s high-cost position, and growing US tariff exposure – and what these dynamics imply for strategy.

In addition, the report provides insight into Roland Berger’s “ Winners ” framework, highlighting the attributes that help outperformers maintain resilience amid industry disruption.

Finally, it outlines a pragmatic set of strategic imperatives for executives, offering actionable guidance on portfolio focus, growth planning, cost resilience, capital structure management, and sharpening the company’s equity story.

The path forward: Adapt, consolidate, or transform

The chemicals industry is entering a phase defined not by incremental shifts but by structural upheaval. Consolidation and take-private transactions are set to accelerate, and companies must decide whether staying public and independent remains viable.

Those that succeed will be the ones who act decisively – reinforcing strategic clarity, sharpening competitiveness, and telling a compelling equity story that resonates with a changing investor universe.

Register now to access the full study. Furthermore, you get regular news and updates directly in your inbox.